このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Paragon 28 マネジメント

マネジメント基準チェック /34

Paragon 28'sの CEO はAlbert DaCostaで、 Jan2012年に任命され、の在任期間は 12.42年です。の年間総報酬は$ 3.23Mで、 21.7%給与と78.3%のボーナス（会社の株式とオプションを含む）で構成されています。は、会社の株式の13.29%を直接所有しており、その価値は$ 66.82M 。経営陣と取締役会の平均在任期間はそれぞれ3.9年と3年です。

主要情報

Albert DaCosta

最高経営責任者

US$3.2m

報酬総額

CEO給与比率	21.7%
CEO在任期間	12.5yrs
CEOの所有権	13.3%
経営陣の平均在職期間	4yrs
取締役会の平均在任期間	3yrs

経営陣の近況

Recent updates

Paragon 28, Inc. (NYSE:FNA) Full-Year Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Mar 03

After Leaping 29% Paragon 28, Inc. (NYSE:FNA) Shares Are Not Flying Under The Radar

Nov 28

Paragon 28 announces public offering of 6.5M shares

Jan 25

Paragon 28 guides Q4 and FY22 revenue outlook above consensus

Jan 10

Paragon 28 GAAP EPS of -$0.13 misses by $0.01, revenue of $46M beats by $3.52M

Nov 10

US$25.00: That's What Analysts Think Paragon 28, Inc. (NYSE:FNA) Is Worth After Its Latest Results

May 12

CEO報酬分析

Paragon 28 の収益と比較して、Albert DaCosta の報酬はどのように変化したか？
日付	総報酬	給与	会社業績
Mar 31 2024	n/a	n/a	-US$54m
Dec 31 2023	US$3m	US$701k	-US$48m
Sep 30 2023	n/a	n/a	-US$67m
Jun 30 2023	n/a	n/a	-US$68m
Mar 31 2023	n/a	n/a	-US$67m
Dec 31 2022	US$5m	US$650k	-US$67m
Sep 30 2022	n/a	n/a	-US$33m
Jun 30 2022	n/a	n/a	-US$29m
Mar 31 2022	n/a	n/a	-US$22m
Dec 31 2021	US$5m	US$615k	-US$14m
Sep 30 2021	n/a	n/a	-US$5m
Jun 30 2021	n/a	n/a	US$4m
Mar 31 2021	n/a	n/a	US$4m
Dec 31 2020	US$933k	US$588k	US$3m

報酬と市場: Albertの総報酬 ($USD 3.23M ) は、 US市場 ($USD 2.43M ) の同規模の企業の平均を上回っています。

報酬と収益: Albertの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Albert DaCosta (50 yo)

12.5yrs

在職期間

US$3,232,421

報酬

Mr. Albert DaCosta is Co-Founder of Paragon 28, Inc. and serves as Chief Executive Officer, President and Director since 2012. Mr. DaCosta is a veteran in the foot and ankle industry with over 18 years of...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Albert DaCosta	Co-Founder	12.5yrs	US$3.23m	13.29% $ 75.4m
Kristina Wright	Independent Interim CFO & Director	no data	US$220.00k	0.022% $ 123.4k
Robert McCormack	General Counsel & Secretary	less than a year	US$1.40m	データなし
Matthew Jarboe	Chief Commercial Officer	6yrs	US$1.53m	0.26% $ 1.5m
Andrew Hill	Executive Vice President of Research & Development	no data	US$1.31m	0.10% $ 587.6k
Jeff Sears	Vice President of Operations	2.5yrs	データなし	データなし
Erik Mickelson	Chief Accounting Officer & Controller	2.3yrs	データなし	0.0054% $ 30.8k
Matt Brinckman	Senior Vice President of Strategy & Investor Relations	2.5yrs	データなし	データなし
Michelle Missal	VP & Chief Compliance Officer	5.5yrs	データなし	データなし
John Shumaker	Executive Vice President of Sales - U.S.	4.5yrs	データなし	データなし
Brendan Shook	Executive VP of Marketing & Medical Education	no data	データなし	データなし
Hans Kestler	Executive Vice President of International	4yrs	データなし	データなし

4.0yrs

平均在職期間

44.5yo

平均年齢

経験豊富な経営陣: FNAの経営陣は経験豊富であると考えられます ( 3.9年の平均在職年数)。

取締役

名称	ポジション	在職期間	報酬	所有権
Albert DaCosta	Co-Founder	12.5yrs	US$3.23m	13.29% $ 75.4m
Kristina Wright	Independent Interim CFO & Director	2.6yrs	US$220.00k	0.022% $ 123.4k
B. Johnson	Independent Director	2.6yrs	US$212.50k	0.032% $ 182.8k
Stephen Newman Oesterle	Independent Director	3.5yrs	US$210.00k	0.029% $ 166.3k
Thomas Schnettler	Lead Independent Director	4yrs	US$245.00k	0.028% $ 156.5k
Quentin Blackford	Independent Director	1.9yrs	US$220.00k	0.029% $ 162.7k
Meghan Scanlon	Independent Director	2.3yrs	US$210.61k	0.024% $ 138.6k
Alf Grunwald	Independent Director	7.4yrs	US$210.00k	0.036% $ 203.7k

3.0yrs

平均在職期間

56.5yo

平均年齢

経験豊富なボード: FNAの取締役会は経験豊富であると考えられます ( 3年の平均在任期間)。

Paragon 28 マネジメント

マネジメント 基準チェック /34

主要情報

経営陣の近況

Paragon 28, Inc., Annual General Meeting, May 17, 2024

Paragon 28, Inc. Announces Chief Financial Officer Changes

Co-Founder recently bought US$255k worth of stock

Jason Edie Step Down from the Position of Chief Technology Officer of Paragon 28, Inc

Chief Commercial Officer exercised options and sold US$1.8m worth of stock

Insider recently sold US$1.1m worth of stock

Recent updates

Investors Give Paragon 28, Inc. (NYSE:FNA) Shares A 27% Hiding

Is Paragon 28 (NYSE:FNA) Using Too Much Debt?

Consensus EPS estimates fall by 32%

Price target decreased by 11% to US$16.00

Paragon 28, Inc. Reaffirms Revenue Guidance for the Year 2024

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Many Still Looking Away From Paragon 28, Inc. (NYSE:FNA)

Paragon 28, Inc., Annual General Meeting, May 17, 2024

Paragon 28, Inc. to Report Q1, 2024 Results on May 08, 2024

New minor risk - Share price stability

Paragon 28, Inc. Announces Chief Financial Officer Changes

Paragon 28, Inc. Adds to Suite of Novel Syndesmosis Repair Solutions with Launch of Grappler®? R3INFORCE™? Extraosseous Repair System

New major risk - Financial position

Co-Founder recently bought US$255k worth of stock

Consensus EPS estimates fall by 24%

Paragon 28, Inc. (NYSE:FNA) Full-Year Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Full year 2023 earnings: EPS misses analyst expectations

Paragon 28, Inc. Provides Earnings Guidance for the Fiscal Year 2024

Paragon 28, Inc. to Report Q4, 2023 Results on Feb 29, 2024

Paragon 28, Inc. Launches Precision®? Mis Bunion System Offering Surgeons A Guided Minimally Invasive Surgical Solution for Treating Patients with Bunions

Paragon 28, Inc. Announces the Launch of the FJ2000™ Power Console and Burr System Designed Specifically for Foot and Ankle Procedures

New minor risk - Shareholder dilution

Paragon 28, Inc. Launches the Mister Tendon™ Harvester System – the First and Only Minimally Invasive Harvesting System for Fhl and Fdl Tendon Transfer Procedures

Paragon 28 Announces First Cases and Limited Market Release of the Bun-Yo-Matic™ – A Next Generation Clamp and Cut Guide System for Lapidus Bunion Procedures

Paragon 28, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year 2023

Paragon 28, Inc. Announce the Launch of the Grappler Knotless Anchor System and Bridgeline Tape

After Leaping 29% Paragon 28, Inc. (NYSE:FNA) Shares Are Not Flying Under The Radar

Paragon 28, Inc. Launches Beast Cortical Fibers

Third quarter 2023 earnings released: US$0.10 loss per share (vs US$0.13 loss in 3Q 2022)

Paragon 28, Inc. Reaffirms Revenue Guidance for the Year 2023

Price target decreased by 8.4% to US$25.00

Paragon 28, Inc. to Report Q3, 2023 Results on Nov 07, 2023

Paragon 28®, Inc. Receives FDA Approval for Ide Feasibility Study of Its Smart Total Talus™ System for Use in Conjunction with the Apex 3D™ Total Ankle Replacement System

New minor risk - Financial position

Second quarter 2023 earnings released: US$0.13 loss per share (vs US$0.13 loss in 2Q 2022)

Paragon 28, Inc. to Report Q2, 2023 Results on Aug 02, 2023

Paragon 28 Launches Comprehensive Supramalleolar Osteotomy System

Jason Edie Step Down from the Position of Chief Technology Officer of Paragon 28, Inc

Paragon 28, Inc. Provides Revenue Guidance for the Year 2023

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus EPS estimates fall by 30%

Full year 2022 earnings: EPS misses analyst expectations

Paragon 28, Inc. to Report Q4, 2022 Results on Mar 02, 2023

Paragon 28, Inc. has completed a Follow-on Equity Offering in the amount of $110.5 million.

Paragon 28 announces public offering of 6.5M shares

Paragon 28, Inc. Announces Preliminary Unaudited Revenue Results for the Fourth Quarter and Full-Year Ended December 31, 2022

Paragon 28 guides Q4 and FY22 revenue outlook above consensus

Chief Commercial Officer exercised options and sold US$1.8m worth of stock

Paragon 28, Inc. Enters Settlement Agreement with Stryker Corp

Consensus forecasts updated

Insider recently sold US$1.1m worth of stock

High number of new directors

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Paragon 28, Inc. Revises Revenue Guidance for the Fourth Quarter and Full Year of 2022

Insider recently sold US$1.1m worth of stock

Paragon 28 GAAP EPS of -$0.13 misses by $0.01, revenue of $46M beats by $3.52M

Paragon 28, Inc. to Report Q3, 2022 Results on Nov 10, 2022

Chief Commercial Officer exercised options and sold US$59k worth of stock

Consensus forecasts updated

Paragon 28, Inc. Announces Board Changes

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Paragon 28, Inc. Revises Revenue Guidance for the Full Year 2022

Paragon 28, Inc. to Report Q2, 2022 Results on Aug 03, 2022

Paragon 28, Inc.(NYSE:FNA) dropped from Russell 2500 Value Index

Key Executive recently sold US$379k worth of stock

Paragon 28, Inc. Launches Monkey Rings™ Circular External Fixation System

Key Executive recently sold US$450k worth of stock

Paragon 28, Inc. Launches TenoTac™ 2.0 Soft Tissue Stabilization System for Hammertoe and Soft Tissue Repair

Consensus forecasts updated

マネジメント基準チェック /34